Greg Pyszczymuka - 30 Jun 2024 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role: Chief Commercial Officer
Signature: /s/ Greg Pyszczymuka
Issuer symbol: AYTU
Transactions as of: 30 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 02 Jul 2024, 17:20:16 UTC
Previous filing: 02 Apr 2024
Next filing: 02 Oct 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AYTU	Common Shares	Options Exercise		+208	+0.91%		22,976	30 Jun 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AYTU	Restricted Stock Units	Options Exercise	$0	-208	-25%	$0.000000	626	30 Jun 2024	Common Shares	208		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted on March 31, 2022, and vest quarterly beginning March 31, 2023 and ending March 31, 2025.